Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical

QR Code

Potential of pigment epithelium-derived factor (PEDF) as a bone regenerative biopharmaceutical

Bone is very much a dynamic tissue, capable of various functions not limited to protection of the marrow, serving as a reservoir for calcium, maintaining posture and facilitating mobility. It is also a tissue that is fully capable of regenerating itself at most stages of life, with a diminishing cap...

Full description

Bibliographic Details
Main Authors:	Lee, P., Dass, Crispin
Format:	Journal Article
Published:	Govi Verlag Pharmazeutischer Verlag GmbH 2016
Online Access:	http://www.ingentaconnect.com/contentone/govi/pharmaz/2016/00000071/00000004/art00001 http://hdl.handle.net/20.500.11937/3547

Similar Items

Pigment epithelium-derived factor: a key mediator in bone homeostasis and potential for bone regenerative therapy
by: Baxter-Holland, M., et al.
Published: (2018)

Insulin antagonises pigment epithelium-derived factor (PEDF)-induced modulation of lineage commitment of myocytes and heterotrophic ossification
by: Carnagarin, R., et al.
Published: (2018)

Stimulation of bone regeneration with pigment epithelium-derived factor microparticles: Evidence in silico, in vitro and in vivo
by: Lee, P., et al.
Published: (2016)

Pigment Epithelium-Derived Factor: Chemistry, Structure, Biology, and Applications
by: Becerra, S.P., et al.
Published: (2012)

Pigment Epithelium-Derived Factor as an Impending Therapeutic Agent Against Vascular Epithelial Growth Factor-Driven Tumor-Angiogenesis
by: Manalo, K., et al.
Published: (2011)

Reduction in tumour cell invasion by pigment epithelium-derived factor is mediated by membrane type-1 matrix metalloproteinase downregulation
by: Filiz, G., et al.
Published: (2012)

Pigment epithelium-derived factor as an anticancer drug and new treatment methods following the discovery of its receptors: a patent perspective
by: Manalo, K., et al.
Published: (2011)

Pigment epithelium-derived factor as a natural matrix metalloproteinase inhibitor: a comparison with classical matrix metalloproteinase inhibitors used for cancer treatment
by: Alcantara, M., et al.
Published: (2014)

Pigment epithelium-derived factor (PEDF) regulates metabolism and insulin secretion from a clonal rat pancreatic beta cell line BRIN-BD11 and mouse islets
by: Chen, Y., et al.
Published: (2016)

Pigment epithelium-derived factor upregulates collagen I and downregulates matrix metalloproteinase 2 in osteosarcoma cells, and colocalises to collagen I and heat shock protein 47 in fetal and adult bone
by: Alcantara, M., et al.
Published: (2014)

Pigment epithelium-derived factor and menopause in metastatic breast cancer
by: Brook, Naomi Louise
Published: (2022)

Efficacy of Continuously Administered PEDF-Derived Synthetic Peptides against Osteosarcoma Growth and Metastasis
by: Broadhead, M., et al.
Published: (2012)

Pigment Epithelium-derived Factor and Insulin Crosstalk in Skeletal Muscle Biology
by: Carnagarin, Revathy
Published: (2017)

The Role of Pigment Epithelium-derived Factor in Breast Cancer Cell Metabolism
by: Abooshahab, Raziyeh
Published: (2025)

The applied biochemistry of PEDF and implications for tissue homeostasis
by: Broadhead, M., et al.
Published: (2010)

The Emerging Role of PEDF in Stem Cell Biology
by: Elahy, Mina, et al.
Published: (2012)

PEDF-induced alteration of metabolism leading to insulin resistance
by: Carnagarin, Revathy, et al.
Published: (2015)

Cell and Molecular Biology Underpinning the Effects of PEDF on Cancers in General and Osteosarcoma in Particular
by: Chandolu, V., et al.
Published: (2012)

Pigment epithelium-derived factor stimulates skeletal muscle glycolytic activity through NADPH oxidase-dependent reactive oxygen species production
by: Carnagarin, R., et al.
Published: (2016)

Alginate bead-encapsulated PEDF induces ectopic bone formation in vivo in the absence of co-administered mesenchymal stem cells.
by: Elahy, M., et al.
Published: (2015)

Systemically administered PEDF against primary and secondary tumours in a clinically relevant osteosarcoma model
by: Broadhead, M., et al.
Published: (2011)

PEDF attenuates insulin-dependent molecular pathways of glucose homeostasis in skeletal myocytes
by: Carnagarin, R., et al.
Published: (2015)

Regulation of MT1-MMP and MMP-2 by the Serpin PEDF: A promising new target for metastatic cancer
by: Alcantara, M., et al.
Published: (2013)

Anti-chondrosarcoma effects of PEDF mediated via molecules important to apoptosis, cell cycling, adhesion and invasion
by: Tan, M., et al.
Published: (2010)

Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy
by: Elahy, M., et al.
Published: (2014)

Peptides for biopharmaceutical applications
by: Agyei, D., et al.
Published: (2018)

Current research on pharmacologic and regenerative therapies for osteoarthritis
by: Zhang, W., et al.
Published: (2016)

Modulatory and regenerative potential of transplanted bone marrow derived mesenchymal stem cells on rifampicin-induced kidney toxicity
by: Danjuma, Lawal, et al.
Published: (2018)

Bone drug targets
by: Dass, Crispin
Published: (2018)

Protein and peptide biopharmaceuticals: An overview
by: Agyei, D., et al.
Published: (2017)

Emerging biopharmaceuticals from bioactive peptides
by: Agyei, D., et al.
Published: (2017)

Aptameric Formulation for Enhanced Biopharmaceutical Delivery
by: Tan, Kei Xian
Published: (2018)

Biopharmaceuticals protection, cure and the real winner
by: Mohd Lila, Mohd Azmi
Published: (2011)

Translation of remote control regenerative technologies for bone repair
by: Markides, Hareklea, et al.
Published: (2018)

Doxorubicin: The dogma and the bone
by: Wong, J., et al.
Published: (2016)

The potential role of free chitosan in bone trauma and bone cancer management
by: Tan, M., et al.
Published: (2014)

Bone morphogenetic protein-2 and bone therapy: Successes and pitfalls
by: Poon, B., et al.
Published: (2016)

Processing and formulation insights for designing quality into lyophilised biopharmaceuticals
by: Beech, Karen E.
Published: (2015)

The potential of tissue engineering and regenerative medicine
by: Sha'ban, Munirah
Published: (2014)

Weak bones in diabetes mellitus - an update on pharmaceutical treatment options
by: Lin, D., et al.
Published: (2017)